First Time Loading...

Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 55.48 USD -0.57% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer healt... [ Read More ]

The intrinsic value of one CTLT stock under the Base Case scenario is 56.13 USD. Compared to the current market price of 55.48 USD, Catalent Inc is Undervalued by 1%.

Key Points:
CTLT Intrinsic Value
Base Case
56.13 USD
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Catalent Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CTLT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Catalent Inc

Provide an overview of the primary business activities
of Catalent Inc.

What unique competitive advantages
does Catalent Inc hold over its rivals?

What risks and challenges
does Catalent Inc face in the near future?

Has there been any significant insider trading activity
in Catalent Inc recently?

Summarize the latest earnings call
of Catalent Inc.

What significant events have occurred
in Catalent Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Catalent Inc.

Provide P/S
for Catalent Inc.

Provide P/E
for Catalent Inc.

Provide P/OCF
for Catalent Inc.

Provide P/FCFE
for Catalent Inc.

Provide P/B
for Catalent Inc.

Provide EV/S
for Catalent Inc.

Provide EV/GP
for Catalent Inc.

Provide EV/EBITDA
for Catalent Inc.

Provide EV/EBIT
for Catalent Inc.

Provide EV/OCF
for Catalent Inc.

Provide EV/FCFF
for Catalent Inc.

Provide EV/IC
for Catalent Inc.

Show me price targets
for Catalent Inc made by professional analysts.

What are the Revenue projections
for Catalent Inc?

How accurate were the past Revenue estimates
for Catalent Inc?

What are the Net Income projections
for Catalent Inc?

How accurate were the past Net Income estimates
for Catalent Inc?

What are the EPS projections
for Catalent Inc?

How accurate were the past EPS estimates
for Catalent Inc?

What are the EBIT projections
for Catalent Inc?

How accurate were the past EBIT estimates
for Catalent Inc?

Compare the revenue forecasts
for Catalent Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Catalent Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Catalent Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Catalent Inc compared to its peers.

Compare the P/E ratios
of Catalent Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Catalent Inc with its peers.

Analyze the financial leverage
of Catalent Inc compared to its main competitors.

Show all profitability ratios
for Catalent Inc.

Provide ROE
for Catalent Inc.

Provide ROA
for Catalent Inc.

Provide ROIC
for Catalent Inc.

Provide ROCE
for Catalent Inc.

Provide Gross Margin
for Catalent Inc.

Provide Operating Margin
for Catalent Inc.

Provide Net Margin
for Catalent Inc.

Provide FCF Margin
for Catalent Inc.

Show all solvency ratios
for Catalent Inc.

Provide D/E Ratio
for Catalent Inc.

Provide D/A Ratio
for Catalent Inc.

Provide Interest Coverage Ratio
for Catalent Inc.

Provide Altman Z-Score Ratio
for Catalent Inc.

Provide Quick Ratio
for Catalent Inc.

Provide Current Ratio
for Catalent Inc.

Provide Cash Ratio
for Catalent Inc.

What is the historical Revenue growth
over the last 5 years for Catalent Inc?

What is the historical Net Income growth
over the last 5 years for Catalent Inc?

What is the current Free Cash Flow
of Catalent Inc?

Financials

Balance Sheet Decomposition
Catalent Inc

Current Assets 2.6B
Cash & Short-Term Investments 229m
Receivables 1.3B
Other Current Assets 1B
Non-Current Assets 7.4B
PP&E 3.8B
Intangibles 3.3B
Other Non-Current Assets 379m
Current Liabilities 1B
Accounts Payable 407m
Accrued Liabilities 341m
Other Current Liabilities 288m
Non-Current Liabilities 5.3B
Long-Term Debt 5B
Other Non-Current Liabilities 306m
Efficiency

Earnings Waterfall
Catalent Inc

Revenue
4.1B USD
Cost of Revenue
-3.4B USD
Gross Profit
735m USD
Operating Expenses
-1B USD
Operating Income
-272m USD
Other Expenses
-1B USD
Net Income
-1.3B USD

Free Cash Flow Analysis
Catalent Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CTLT Profitability Score
Profitability Due Diligence

Catalent Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Negative Operating Income
38/100
Profitability
Score

Catalent Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

CTLT Solvency Score
Solvency Due Diligence

Catalent Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Low Altman Z-Score
31/100
Solvency
Score

Catalent Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTLT Price Targets Summary
Catalent Inc

Wall Street analysts forecast CTLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTLT is 57.83 USD with a low forecast of 42.42 USD and a high forecast of 66.68 USD.

Lowest
Price Target
42.42 USD
24% Downside
Average
Price Target
57.83 USD
4% Upside
Highest
Price Target
66.68 USD
20% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CTLT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CTLT Price
Catalent Inc

1M 1M
-1%
6M 6M
+32%
1Y 1Y
+25%
3Y 3Y
-49%
5Y 5Y
+26%
10Y 10Y
+178%
Annual Price Range
55.48
52w Low
31.86
52w High
59.82
Price Metrics
Average Annual Return 17.08%
Standard Deviation of Annual Returns 60.59%
Max Drawdown -78%
Shares Statistics
Market Capitalization 10B USD
Shares Outstanding 180 738 000
Percentage of Shares Shorted 5.25%

CTLT Return Decomposition
Main factors of price return

What is price return decomposition?

CTLT News

Other Videos

Last Important Events
Catalent Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Catalent Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Catalent Inc Logo
Catalent Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

10B USD

Dividend Yield

0%

Description

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company is headquartered in Somerset, New Jersey and currently employs 17,300 full-time employees. The company went IPO on 2014-07-31. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.

Contact

NEW JERSEY
Somerset
14 Schoolhouse Rd
+17325376200.0
https://www.catalent.com/

IPO

2014-07-31

Employees

17 300

Officers

President, CEO & Director
Mr. Alessandro Maselli
Group President of Pharma & Consumer Health Segment
Dr. Aristippos Gennadios Ph.D.
President, Division Head for BioProduct Delivery & Chief of Staff
Mr. Ricky Hopson
Executive Chairman of the Board
Mr. John J. Greisch M.B.A.
Senior VP & CFO
Mr. Matti M. Masanovich
VP & Chief Accounting Officer
Mr. Michael J. Hatzfeld Jr.
Show More
Senior VP & Chief Information Officer
Mr. Charles Lickfold
Vice President of Investor Relations
Mr. Paul Surdez
Senior VP, General Counsel, Chief Compliance Officer & Secretary
Mr. Joseph A. Ferraro J.D.
Senior Vice President of Strategy & Corporate Development
Mr. Michael J. Grippo
Show Less

See Also

Discover More
What is the Intrinsic Value of one CTLT stock?

The intrinsic value of one CTLT stock under the Base Case scenario is 56.13 USD.

Is CTLT stock undervalued or overvalued?

Compared to the current market price of 55.48 USD, Catalent Inc is Undervalued by 1%.